Explore our range of Phallus products — FDA-approved, clinically tested, and delivered discreetly to your door.



Phallus Power is a high-dose sildenafil citrate brand manufactured by Lotus Biotech Ltd., an Indian pharmaceutical company specializing in above-standard sildenafil formulations designed for men whose ED severity has outgrown what conventional 50 mg or 100 mg doses can address. The product line spans three doses — 110 mg, 160 mg, and 210 mg — with each tier targeting a progressively more challenging ED presentation.
The active ingredient, sildenafil citrate, is the world's most extensively studied ED molecule — the same compound first developed by Pfizer and approved by the U.S. FDA in 1998 under the brand name Viagra. With decades of clinical evidence across thousands of trials and hundreds of millions of prescriptions, sildenafil's mechanism, safety profile, and dose-response relationship are better understood than virtually any other medication in pharmacology.
What makes Phallus Power clinically relevant is the dose-response relationship of sildenafil: as dose increases, both the depth of PDE5 inhibition and the plasma concentration of active sildenafil increase in a clinically meaningful way. For men whose underlying vascular or neurological compromise reduces the signal-to-noise ratio of the erection pathway — where a 100 mg dose simply cannot push through the biological resistance — a carefully titrated higher dose can cross the threshold and restore functional erectile performance.
Understanding why above-standard sildenafil doses are medically necessary — and not simply an excess — requires understanding how the erection mechanism degrades under different medical conditions. The standard 100 mg sildenafil dose was established as a maximum approved dose based on clinical trials in a broadly representative adult male population. But that population average conceals significant individual variation — particularly among men with conditions that biologically raise the pharmacological threshold needed to achieve an adequate erectile response.
Several well-documented conditions reduce the effectiveness of standard sildenafil doses by directly weakening the physiological substrate it works on:
Here's the complete clinical picture of how sildenafil dosing maps to ED severity and patient population:
Dose Tier | Typical Indication | Clinical Population | Efficacy Expectation |
25–50 mg | First-line, mild ED | Healthy men under 50, no significant comorbidities | High — 70–80% success rates |
100 mg | Standard, moderate ED | Most men, first-line standard dose | High — 75–82% success rates |
110 mg (Phallus 110) | Step-up, mild–moderate | Men with partial 100 mg response | Good — modest improvement over 100 mg |
160 mg (Phallus 160) | High-dose, moderate–severe | Diabetic, hypertensive, or older men | Improved for comorbid populations |
210 mg (Phallus 210) | Maximum, severe/refractory | Men with treatment-resistant or severe ED | Clinically necessary for non-responders |
Phallus Power fills the upper two rungs of this ladder — the doses that are clinically necessary for men whose ED cannot be adequately treated at 100 mg and below. These are not experimental dose levels; they reflect the documented upper range of sildenafil's therapeutic dose-response curve.
Each Phallus Power formulation is a film-coated oral tablet containing sildenafil citrate at a precise high-dose concentration. The clinical distinction between the three tiers is the degree of PDE5 inhibition — and therefore the clinical severity of ED each is designed to address. Here's a clear overview:
Variant | Dose | ED Severity | Who It Is For |
Phallus Power 110 mg | 110 mg | Mild–moderate | Men stepping up from standard 100 mg sildenafil with insufficient response |
Phallus Power 160 mg | 160 mg | Moderate–severe | Men with diabetes or hypertension-related ED, step-up from 110 mg |
Phallus Power 210 mg | 210 mg | Severe/treatment-resistant | Men with clinically severe ED requiring maximum sildenafil potency |
Phallus Power 110 mg is the entry point into the Phallus range — a 10% dose increase above the standard 100 mg sildenafil ceiling. This modest increment is more pharmacologically meaningful than it appears: the dose-response relationship of sildenafil is non-linear at the upper range, meaning that a 10% dose increase can produce a disproportionately greater improvement in erection quality for men who are biologically close to the 100 mg efficacy threshold but cannot consistently cross it.
Phallus Power 110 mg is the appropriate starting point for men who have tried standard 100 mg sildenafil — from brands like Cenforce, Kamagra, or Fildena — and found that it works partially but not reliably or not with satisfactory rigidity. It represents a calibrated clinical escalation, not a leap to the maximum dose. Our Phallus Power 110 mg is the most cautious entry point into high-dose sildenafil therapy and the right starting dose for physician-supervised escalation.
Phallus Power 160 mg targets the population that needs it most: men whose erectile dysfunction is compounded by one or more chronic medical conditions that directly impair the sildenafil response pathway. This dose delivers sildenafil at 60% above the standard ceiling — a pharmacological depth that produces meaningfully greater peak plasma concentration and more sustained PDE5 inhibition in men whose compromised vascular and neurological substrate requires it.
This is the dose most commonly appropriate for: men with type 2 diabetes and ED who have not responded adequately to 100 mg sildenafil; men over 60 with atherosclerotic penile artery disease; men who are on antihypertensive medications that partially antagonize the erection pathway; and men post-prostatectomy who retain some nerve function but need higher pharmacological amplification to activate it. Our Phallus Power 160 mg is available in multiple pack sizes to support ongoing, consistent treatment at this clinically important dose tier.
Phallus Power 210 mg is the highest sildenafil dose in the Phallus range — and among the highest single-dose sildenafil formulations available anywhere. At more than double the standard 100 mg dose, Phallus Power 210 mg delivers the deepest possible pharmacological PDE5 inhibition that sildenafil-based therapy can achieve in an oral tablet format.
This dose is intended for men with clinically severe or treatment-resistant erectile dysfunction — men who have tried multiple sildenafil doses and found them insufficient, and who require the maximum available pharmacological response to achieve any clinically satisfactory erection. It is also the dose that carries the highest side effect risk profile — which is why Phallus Power 210 mg is strictly a physician-supervised medication, not a self-initiated dose escalation.
At 210 mg, the vasodilatory, blood pressure-lowering, and cardiovascular effects of sildenafil are at their most pronounced, and drug interaction risks are amplified. Full cardiovascular clearance and complete medication review are essential before starting this dose. Our Phallus Power 210 mg is available for men who have been clinically assessed and advised to use maximum-strength sildenafil therapy.
The pharmacological mechanism of Phallus Power is identical to standard sildenafil — what changes at higher doses is the depth and duration of that mechanism's effect. Understanding the complete pathway illuminates why dose escalation is clinically meaningful for the right patient.
Sexual stimulation activates NANC (non-adrenergic non-cholinergic) nerve terminals in the penile corpus cavernosum, triggering the release of nitric oxide (NO). This NO signal activates guanylate cyclase, which converts GTP to cyclic guanosine monophosphate (cGMP) — the master vasodilatory signal in the erection cascade.
Elevated cGMP causes smooth muscle cells in the cavernous arterioles to relax, dramatically increasing penile arterial inflow. As pressure builds within the corpus cavernosum, the tunica albuginea compresses emissary veins, trapping blood and sustaining erection. The quality of erection — rigidity, duration, maintainability — correlates directly with the peak and sustained level of intracavernous cGMP.
In men with erectile dysfunction, the PDE5 enzyme degrades cGMP faster than the body can maintain adequate levels for satisfactory erection. In men with vascular compromise or nerve damage, the NO signal initiating cGMP synthesis is itself weakened — creating a double deficit: lower cGMP production and persistent PDE5-driven degradation.
Sildenafil binds competitively to the catalytic site of PDE5, blocking cGMP degradation. With PDE5 suppressed, cGMP accumulates — and at higher sildenafil doses, the inhibition of PDE5 is deeper and more sustained. In men where 100 mg of sildenafil inhibits PDE5 insufficiently to maintain the cGMP threshold, 160 mg or 210 mg of Phallus Power achieves the additional inhibitory depth needed.
One pharmacokinetic factor that few discussions of sildenafil adequately address: sildenafil is metabolized in the liver primarily by CYP3A4 enzymes into its active metabolite N-desmethyl sildenafil, which retains approximately 50% of sildenafil's PDE5 inhibitory potency. This means that a 210 mg dose of Phallus Power generates both high circulating sildenafil levels and a substantial active metabolite contribution — extending both the peak potency and the tail duration of PDE5 inhibition relative to lower doses. Peak plasma concentration is typically reached within 30 to 120 minutes after ingestion, with overall clinical effect lasting 4 to 6 hours.
When comparing Phallus Power to any standard sildenafil generic — whether Cenforce 100, Kamagra 100, Fildena 100, or Viagra itself — the fundamental distinction is one of pharmacological depth, not mechanism. Here's exactly what changes at higher doses:
Higher sildenafil doses produce proportionally higher peak plasma concentrations. At 210 mg, peak circulating sildenafil levels are substantially greater than at 100 mg — producing a more complete inhibition of available PDE5 enzyme and maintaining that inhibition above the therapeutic threshold for a longer period within the 4-to-6-hour active window.
PDE5 inhibition by sildenafil follows a concentration-dependent curve: the more sildenafil is present, the greater the proportion of available PDE5 enzyme that is inhibited. In men whose ED is characterized by either excessive PDE5 activity or reduced NO/cGMP production, this added depth of inhibition is what makes the difference between a partial erection and a clinically satisfactory one.
Higher doses of sildenafil produce more pronounced vasodilatory effects systemically — which means that the common sildenafil side effects (headache, flushing, dizziness, nasal congestion) are more frequently reported and more intense at 160 mg and 210 mg than at 100 mg. The cardiovascular effects — blood pressure reduction, heart rate changes — are also more pronounced. This is why physician supervision is essential at these dose tiers, and why cardiovascular health screening before use is non-negotiable.
It is worth addressing the comparison directly, since many men searching for high-dose sildenafil encounter both products. Cenforce 200 mg (manufactured by Centurion Laboratories) is a double-strength 200 mg sildenafil tablet — well-established in the generic ED market and available from our store. Phallus Power 210 mg adds an additional 10 mg above that ceiling, making it the highest single-dose sildenafil tablet in our catalog. For men who have tried Cenforce 200 mg and require marginally more, Phallus Power 210 mg is the precise next step.
We carry the most comprehensive sildenafil range available from any single store. Here's how Phallus Power sits within that lineup — and how to determine which brand and dose best fits your needs.
Men with mild-to-moderate ED who respond well to 25 mg, 50 mg, or 100 mg sildenafil have the best selection of options within our standard sildenafil range — Cenforce, Kamagra, Fildena, and more — all of which deliver identical clinical sildenafil performance at competitive prices. Phallus Power is not the first choice for this group.
Other brands in our Blue Pill range offer above-standard sildenafil formulations alongside their standard doses. Sildigra and Stallegra both include higher-dose sildenafil variants within their respective brand families. Phallus Power's unique position is its exclusive focus on above-standard dosing — the entire range begins at 110 mg, making it the specialist high-dose option in our sildenafil catalog rather than an add-on to a broader standard-dose line.
For men who want our own-branded sildenafil at maximum value pricing, Careforce is our in-house sildenafil option — a reliable, competitively priced generic for men whose ED is well-managed at standard doses. When standard doses are not enough, Phallus Power is the natural escalation within our catalog.
If the reason standard sildenafil has not worked is not about dose insufficiency — but rather about duration, food interaction constraints, or the need for BPH co-treatment — then the issue may be one of molecule, not dose. In those cases, tadalafil (Vidalista 60 mg and above) or vardenafil are better solutions than escalating sildenafil. For men with severe ED who also want to explore tadalafil at higher doses, our Vidalista 60 mg is a high-strength tadalafil option that directly addresses this scenario.
Take the prescribed Phallus Power dose orally with a full glass of water approximately 30 to 60 minutes before planned sexual activity — though many men with slower metabolism benefit from taking it 60 to 90 minutes before for maximum peak concentration timing. Swallow the tablet whole; do not crush, chew, or split it. Take only one dose per 24-hour period. Never combine Phallus Power with any other PDE5 inhibitor on the same day.
Sildenafil can be taken with or without food. However, high-fat meals significantly delay absorption — a large fatty meal consumed within 1–2 hours of taking Phallus Power can delay peak plasma concentration by up to 60 minutes and reduce maximum plasma concentration (Cmax) by approximately 29%. At high doses where timing precision matters more, taking Phallus Power on an empty stomach or after a light, low-fat meal is strongly recommended for consistent, predictable results.
Grapefruit and grapefruit juice contain furanocoumarins that inhibit CYP3A4 — the primary liver enzyme responsible for metabolizing sildenafil. At standard sildenafil doses, this interaction produces moderately elevated drug levels. At Phallus Power doses (110 mg–210 mg), where plasma sildenafil concentrations are already substantially higher, inhibiting CYP3A4 through grapefruit can produce dangerously amplified drug levels, dramatically increasing the risk of severe side effects. Avoid all grapefruit products entirely on any day you take Phallus Power.
Moderate alcohol consumption (1 standard drink) has minimal direct pharmacokinetic interaction with sildenafil. However, at Phallus Power's higher doses, even moderate alcohol can amplify the blood pressure-lowering effect to symptomatic levels — producing dizziness, lightheadedness, or fainting. Heavy drinking (5+ drinks) compounds both the hypotensive interaction and directly impairs the central arousal signaling that sildenafil depends on. Avoid alcohol on days you take Phallus Power, especially at the 160 mg and 210 mg doses.
Phallus Power — at any dose — does not produce spontaneous erections. The mechanism depends entirely on the presence of sexual arousal to trigger the nitric oxide release that initiates cGMP synthesis. Without genuine sexual stimulation, even the highest dose will produce no erection response. This is a feature of all PDE5 inhibitors, not a limitation of Phallus Power. The drug amplifies the physiological response to arousal; it does not replace it.
At standard sildenafil doses, the side effect profile is well-characterized and generally mild. At Phallus Power's above-standard doses, the same side effects occur — but with greater frequency and intensity in proportion to the higher plasma drug concentration. This is a pharmacologically expected and clinically manageable reality, not an indicator of product quality issues.
At above-standard sildenafil doses, the contraindication profile becomes even more critical than at 50 mg or 100 mg. The following groups should not use Phallus Power under any circumstances:
Severe erectile dysfunction — the form of ED for which Phallus Power's higher doses are designed — is not simply "worse ED." It is often a condition with a fundamentally different pathophysiological basis than mild or moderate ED. Understanding what drives it explains why standard doses fail and why high-dose sildenafil is clinically justified.
The single most common cause of severe ED is advanced penile vascular disease — arterial endothelial dysfunction, atherosclerotic narrowing of the pudendal and cavernous arteries, and reduced arterial compliance. In these men, the penile arterial tree is genuinely compromised mechanically and biochemically. No amount of smooth muscle relaxation will compensate for an artery that is physically narrowed to a fraction of its normal lumen. PDE5 inhibitors at high doses maximize the pharmacological vasodilatory signal in whatever vascular capacity remains — but they cannot repair damaged arteries. This is why severe vascular ED often represents the hardest-to-treat category.
For men with type 2 diabetes, erectile dysfunction is an expected complication that affects up to 75% of diabetic men over 60. Diabetes attacks the erection pathway from two directions simultaneously: microvascular damage reduces arterial flow capacity, and autonomic neuropathy impairs the nerve-mediated NO release that initiates the entire cGMP cascade. For these men, standard sildenafil doses inhibit PDE5 effectively — but the substrate they're working on (NO production and vascular responsiveness) is so severely compromised that standard inhibition levels are not enough to produce a usable erection. Higher doses push through this biological resistance for a significant proportion of diabetic non-responders.
Radical prostatectomy for prostate cancer causes erectile dysfunction in the majority of men who undergo it, even with nerve-sparing surgical techniques. The cavernous nerves that run alongside the prostate and control penile NO release are frequently damaged or divided during surgery — producing a severe neurogenic ED that standard sildenafil doses frequently cannot overcome. High-dose PDE5 inhibition, combined with penile rehabilitation protocols, represents the primary pharmacological tool for recovering erectile function in this population.
For a broader perspective on what influences male sexual performance and physiological development, our men's health blog covers the full spectrum of ED drivers, treatment options, and lifestyle considerations that matter to American men at every age.
For men with severe ED who are using high-dose sildenafil, lifestyle optimization is not optional — it is a clinical multiplier that directly influences how much pharmacological benefit Phallus Power can deliver. The biological barriers that make high-dose sildenafil necessary are often the same barriers that respond to lifestyle intervention.
For men whose ED overlaps with concerns about women's sexual health in their relationship context, our comprehensive Women's Health section addresses female sexual wellbeing and treatment options — including our Female Viagra range for women dealing with sexual dysfunction in parallel.
High-dose sildenafil is a category where sourcing quality, pricing transparency, and ordering privacy matter even more than usual. Here's what we guarantee:
For men with a clear clinical need, appropriate cardiovascular health clearance, no contraindicated medications, and physician supervision, high-dose sildenafil — including 210 mg — can be taken with acceptable safety. The critical requirements are: no concurrent nitrate medication, no severe cardiovascular instability, and no potent CYP3A4-inhibiting drugs. Without these clearances, high-dose sildenafil carries unacceptable risk. This is not a dose to self-prescribe or take out of curiosity — it is a clinical intervention for men with genuine pharmacological need.
It depends on why 100 mg failed. If the failure was due to insufficient PDE5 inhibition in the context of a compromised vascular or neurological substrate — as is common in diabetic or severely vascular ED — then a higher dose may produce meaningfully better results. If the failure was due to inadequate sexual stimulation, the wrong timing of the dose, food interference, or a psychological rather than physical cause, then dose escalation alone is unlikely to solve the problem. A physician assessment of why 100 mg sildenafil failed is the right starting point before escalating to Phallus Power 210 mg.
This depends entirely on the specific medication. Most ACE inhibitors, ARBs, and calcium channel blockers can be combined with sildenafil at appropriate doses with physician monitoring. Alpha-blockers used for BPH or hypertension interact with sildenafil to produce additive hypotension — at high doses of Phallus Power, this interaction is amplified and requires careful timing and dose management. Beta-blockers carry lower hypotensive interaction risk. Nitrate-based blood pressure medications are absolutely contraindicated. Always provide your complete medication list to your prescribing physician before starting any dose of Phallus Power.
Both are high-dose sildenafil generics, and the pharmacological difference between 200 mg and 210 mg is clinically modest. The distinction is one of manufacturer, formulation, and dose increment precision. Cenforce 200 mg is manufactured by Centurion Laboratories; Phallus Power 210 mg is manufactured by Lotus Biotech. For men who have used Cenforce 200 mg and want to explore the marginal additional dose increment, Phallus Power 210 mg offers that precision step-up.
Sildenafil is not known to have a clinically significant negative effect on sperm quality or fertility in most men. Some research has suggested that at very high doses, sildenafil may alter certain sperm parameters in sensitive populations — but clinical consensus does not identify sildenafil as a significant fertility risk at therapeutic doses. Men with fertility concerns should discuss all medications, including Phallus Power, with a reproductive urologist or endocrinologist.
Severe ED Has a Pharmacological Answer. Phallus Power Is It.
For the millions of American men for whom standard 100 mg sildenafil is simply not enough — because of diabetes, cardiovascular disease, surgical history, or the biological realities of severe erectile dysfunction — Phallus Power offers a clinically structured, physician-supervised path to effective treatment. Three dose tiers, one specialized manufacturer, and the same proven sildenafil molecule — delivered at the depth that severe ED actually demands.
Explore our full Phallus Power collection today. For questions about which dose is appropriate for your specific situation, contact our team 24/7: +1 (914) 999-2631 or support@edcarestore.com. Discreet packaging. Genuine product. Nationwide delivery.
Medical Disclaimer
The content on this page is provided for informational purposes only and does not constitute medical advice, diagnosis, or treatment. High-dose sildenafil (including all Phallus Power formulations) should only be taken under the supervision of a qualified, licensed healthcare provider who has assessed your cardiovascular health, full medication list, and specific clinical indication. ED Care Store does not diagnose, treat, cure, or prevent any medical condition. All products are subject to applicable prescription requirements and legal compliance in the purchaser's jurisdiction.